Monivent
Camilla has 21 years’ experience in life science and has a Cand. Scient degree in toxicology from the University of Oslo. She has a broad experience in business development and marketing and has previously worked at Dynal Biotech, GE Healthcare and BioLamina AB. Camilla is currently CEO of Miris Holding AB and board member of NextCell Pharma AB.
This person is not in the org chart
This person is not in any teams
Monivent
Monivent offers products that increases patient safety for newborn babies requiring help to start breathing at birth.